Normal labor and delivery. Spontaneous vertex delivery
Conditions
Interventions
Intervention 1: The first intervention group: 80 to 240 ml syrup (made by Yashil drug company, Aras)containing 750 mg saffron and 200 mg of sugar palms in 240 ml syrup. 80 ml of the syrup will be tak
Treatment - Drugs
The first intervention group: 80 to 240 ml syrup (made by Yashil drug company, Aras)containing 750 mg saffron and 200 mg of sugar palms in 240 ml syrup. 80 ml of the syrup will be taken when cervical
The second intervention group: 80 to 240 ml syrup (made by Yashil drug company, Aras) containing 750 mg saffron and artificial sugar (Isonalt) in 240 ml syrup. 80 ml of the syrup will be taken when ce
Control group: 80 to 240 ml syrup (made by Yashil drug company, Aras) containing placebo of saffron and artificial sugar (Isonalt) in 240 ml syrup (identical in color, smell and taste with the saffron
Sponsors
Vice chancellor for research, Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: aged 18 to 35 years; nulliparous; gestational age of 38 to 41 weeks; spontaneous onset of labor; singleton pregnancy with estimated fetal weight of 2500 to 4000 grams and cephalic presentation; no use of any herbal and anti anxiety drugs in the past 12 hours; reactive non stress test; body mass index of 19.8 to 30 kg/m²; having 8 years education or higher. Exclusion criteria: history of surgery on the uterus, cervix or vagina; allergy to saffron; known chronic diseases including hypertension, diabetes, diseases of the respiratory, cardiovascular, endocrine, etc.; history of mental illnesses; speech, hearing, visual or mental problems; known indications for caesarean section; premature rupture of membranes for more than 12 hours; any known fetal abnormalities; known fetal growth retardation
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of labor pain. Timepoint: every one hour from about 3 cm cervical dilation to the end of the second stage of labor; one and 18 to 24 hours after delivery. Method of measurement: visual analogue scale (VAS) for pain.;Intensity of anxiety. Timepoint: at baseline, 3 to 4 hours after starting intervention, and 18 to 24 postpartum. Method of measurement: Spielberger state questionnaire and visual analogue scale for anexity. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of first stage of labor (active phase). Timepoint: from 4 cm to 10 cm cervical dilatation. Method of measurement: Partogramm form.;Duration of second stage of labor. Timepoint: from 10 cm cervical dilation to delivery. Method of measurement: Partogramm form.;Duration of third stage of labor. Timepoint: immediately after birth to expultion of placenta and fetal membranes. Method of measurement: Partogramm form.;Hemoglobin. Timepoint: at baseline and 18 to 24 hours after birth. Method of measurement: labratory test.;Score of delivery experience. Timepoint: 18 to 24 hour after delivery. Method of measurement: delivery experience questionnaire.;Woman satisfaction rate. Timepoint: 18 to 24 hour after delivery. Method of measurement: one question with likert options.;Amount of oxytocin used. Timepoint: during the intervention. Method of measurement: observation.;Hematocrit. Timepoint: at baseline and 18 to 24 hours after birth. Method of measurement: labratory test.;Newborn bilirubin. Timepoint: 18 to 24 hours after delivery. Method of measurement: Billi Check device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRoghayeh mohammadie rad
Nursing & Midwifery Faculty, Tabriz University of Medical Sciences
Outcome results
None listed